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This paper focuses on radiological approach in pediatric stroke including both ischemic stroke (Arterial Ischemic Stroke and
Cerebral Sinovenous Thrombosis) and hemorrhagic stroke. Etiopathology and main clinical ﬁndings are examined as well.
Magnetic Resonance Imaging could be considered as the ﬁrst-choice diagnostic exam, oﬀering a complete diagnostic set of
information both in the discrimination between ischemic/hemorrhagic stroke and in the identiﬁcation of underlying causes. In
addition, Magnetic Resonance vascular techniques supply further information about cerebral arterial and venous circulation.
Computed Tomography, for its limits and radiation exposure, should be used only when Magnetic Resonance is not available and
on unstable patients.
1.Introduction
Pediatric stroke (PS) is a relatively rare disease, having
an estimated incidence of 2.5–13/100,000/year [1–4], but
remains one of the most common causes of death in
childhood, with a mortality rate of 0.6/100,000 dead/year
[5, 6]. PS has also seriously high morbidity and long-term
outcome and is nowadays gaining more interest because of
its heavy consequences and costs, both personal and social.
Indeed, about half of the surviving patients develop some
neurologic or cognitive impairment, and just more than a
quarter, epilepsy.
As in adults, PS can be ischemic or hemorrhagic;
although ischemic stroke is more common, prevalence is
variable [7, 8]. Ischemic stroke includes Arterial Ischemic
Stroke (AIS) and Cerebral Sinovenous Thrombosis (CSVT);
Hemorrhagic Stroke (HS) includes intracerebral and sub-
arachnoid haemorrhage [9].
AIS, both in neonatal and childhood forms, has a higher
incidence among males [5, 10–14] and black people [5, 7].
AIS is relapsing in 6%–37% of little patients [15–19]a n d
the risk appears highest in the ﬁrst 6 months after the ﬁrst
episode [19, 20]. Risk factors for relapse include vascular
abnormalities as ﬁrst stroke cause [19, 20], and the presence
of thrombotic risk factors [20], either isolated or as part of
multiple risk factors [20, 21].
CSVT has an incidence of 2.6/100,000 children/year in
the neonatal period and of 0.4 and 0.7/100,000 children/year
in childhood [22].
The incidence of hemorrhagic stroke (HS) is estimated
between0.7to5.1/100,000children/year[23,24]and,similar
to childhood AIS, is more common in males and blacks [11,
25]. The mean age at diagnosis is 6–10 years [1].
A prompt and precise diagnosis of PS, associated to an
eﬀective management of vascular emergencies, is a crucial
point to reach a correct therapy and, consequently, a positive
outcome.
This paper will focus on main clinical features and
radiological diagnosis of pediatric stroke.
2.CauseandPathophysiology
2.1. Ischemic Stroke
2.1.1. Arterial Ischemic Stroke
AIS is deﬁned as ischemia, infarction, or encephalomalacia
in a vascular arterial distribution territory [5].2 Stroke Research and Treatment
ClassiﬁcationofAIShasalwaysbeenobjectofdebatethus
leading to the development of diﬀerent systems. The need
to subclassify patients with AIS arises from several reasons.
In fact, prognosis, risk of recurrence, etiological factors, and
choices of management diﬀer between the subtypes. AIS
can be divided into subgroups according to PSC (Pediatric
Stroke Classiﬁcation) proposed by Wraige et al. [26]. This
classiﬁcation is based on main etiopathological diﬀerences
between pediatric and adult stroke and derives from the
TOAST one, used for adult stroke [27]. PSC includes eight
subtypes of AIS: (1) sickle cell disease, (2) cardioembolic, (3)
Moya-Moya Syndrome, (4) cervical arterial dissection, (5)
steno-occlusive cerebral arteriopathy, (6) other determined
etiology, (7) multiple probable/possible etiologies, and (8)
undetermined etiology.
Pediatric AIS shares with adult AIS an embolic or in
situ thrombosis ground but, unlike adult stroke, degen-
erative vascular and chronic degenerative diseases (e.g.,
atherosclerosis) have very little role in its genesis. Most
frequently reported risk factors for pediatric AIS are congen-
ital or acquired heart diseases, hematologic and metabolic
disorders, and vascular disorders and infections [21, 28].
Nevertheless, approximately one half of pediatric AIS occurs
in children with unknown risk factors [29].
Predisposing factors for AIS are summarized in Table 1.
Vasculopathies such as Transient Cerebral Arteriopathy
(TCA), arterial dissection, ﬁbromuscular dysplasia, and
Moya-Moya Disease (MMD) have been identiﬁed in 18%–
80% of children with AIS [19]. Congenital heart disease is
reported in association with large vessel dissection or MMD
[30, 31].
The most common arteriopathy associated with pedi-
atric stroke is TCA. This is a monophasic arterial disease
characterized by a unilateral focal or segmental stenosis,
which involves the distal part of the internal carotid and
the initial segments and branches of the anterior and/or
middle cerebral artery, and is followed by complete or partial
resolution [32].
The pathophysiology of TCA is uncertain but in 44% is
associated with Post-Varicella Arteriopathy (PVA), an acute
vasculitis caused by varicella virus infection of the arterial
wall. In this cases a varicella zoster infection is identiﬁed in
the 12 months prior to AIS [33, 34].
Other infectious agents, which are frequently respon-
sible for TCA, are Parvovirus B19, CMV, Mycoplasma
pneumoniae, Borrelia burgdorferi, Enterovirus, HIV, and
Helicobacter pylori.
Furthermore, some patients with TCA present angiog-
rams compatible with arterial dissections [22, 35].
MMD is a progressive bilateral stenosis of Willis circle
arteries, which usually causes vascular insuﬃciency or
repeated ischemic episodes, despite the development of
collateral blood ﬂow [36]. It can be primary or secondary
to underlying disorders, in which case it is known as Moya-
Moya Syndrome.
Primary or idiopathic MMD accounts for 12% of AIS
cases [37].
The most common hematologic risk factor of stroke
is Sickle Cell Disease (SCD). In this disease hemoglobin,
in a deoxygenated environment, acquires higher density
making red blood cells susceptible to sickle. SCD has a lot of
neurologic complication, among them cerebral infarction is
the most common. The stroke pathophysiology in SCD may
be a combination of chronic haemolytic anemia and vaso-
occlusion [38]. Indeed, chronic hemolysis leads to anemia
and subsequently to tissue hypoxia; anemia determines
increased stress and red cell adhesion to endothelial cells
with consequent injury. Damaged endothelial cells suﬀer
alterations, including intimal hyperplasia and prothrom-
botic/proadhesive events. On the other hand, vaso-occlusion
decreases blood ﬂow, leading to tissue ischemia and infarc-
tion.
Alterations in vasoregulation generate a cascade precipi-
tating acute cerebrovascular events [39].
Prothrombotic disorders such as protein C and protein
S deﬁciency, antithrombin III deﬁciency, factor V Leiden
mutation, factor XII deﬁciency, factor VIII deﬁciency, pro-
thrombin 20210A mutations, and antiphospholipid anti-
bodies have been found in approximately one third of
children with AIS [40, 41].
Congenital metabolism errors such as Fabry disease,
homocystinuria, organic acid disorders, ornithine trans-
carbamylase deﬁciency, and carbohydrate-deﬁciency glyco-
protein syndrome are also well-established risk factors of
children AIS [42].
Another important cause of pediatric stroke is sub-
stance abuse, especially in teenage patients. Drugs such as
amphetamines, ecstasy, cocaine, and inhalants (such as glue
sniﬃng) have been shown to be a risk for stroke from
both cerebral infarct and hemorrhage. The use of marijuana
h a sb e e nr e p o r t e da sac a u s eo fs t r o k e sw i t hc e r e b e l l a r
infarction among adolescents [43]. Strokes related to these
substances are thought to be caused by toxic vasculitis,
transient cerebral vasoconstriction, prothrombotic eﬀects,
and exacerbation of previously unrecognized cardiovascular
disease [23, 44] .T h er i s ko fs t r o k eh a sb e e np l a c e da sh i g h
as 6.5 per 100,000 per year in young adult drug abusers
[45].
2.1.2. Cerebral Sinovenous Thrombosis. Thrombosis within
the venous system results in outﬂow obstruction with
subsequent venous congestion and persistent increase in
capillary hydrostatic pressure, which drives ﬂuid into inter-
stitium producing edema. An increased hydrostatic pres-
sure reduces also arterial inﬂow with subsequent ischemia
[22].
The brain injury spectrum in CSVT varies from venous
congestion to parenchymal ischemic injury, which may be
cortical, subcortical, or involving deep gray matter.
Most of the parenchymal infarcts are hemorrhagic but
CSVT can also lead to subarachnoid/subdural hemorrhage.
In preterm and term neonates there is also an association
between CSVT and intraventricular hemorrhage (IVH) [22,
46]. Indeed, several studies demonstrate that CSVT is the
most frequently identiﬁed cause of symptomatic IVH, and is
associated, in term neonates, with basal ganglia or thalamic
hemorrhage.Stroke Research and Treatment 3
Table 1: Risk factors and causes of Arterial Ischemic Stroke.
Cardiac
(1) Congenital
(a) Dysrhythmias
(b) Congenital heart disease
(c) Cardiomyopathy
(d) Cardiac tumours
(2) Acquired
(a) Cardiomyopathy
(b) Carditis
(c) Arrhythmias
(d) Artiﬁcial valves
(e) Endocarditis
(3) Iatrogenic
(a) Cardiac catheterization
(b) Cardiac surgery/cardiopulmonary bypass
(c) Carotid ligation
Hematologic
(1) Hemoglobinopathies
(a) Sickle Cell Disease
(b) Thalassemia
(2) Thrombophilia
(a) Primary
(b) Secondary
(3) Iron deﬁciency anemia
(4) Thrombocytopenia
Infectious
(1) Meningitis
(a) Viral, bacterial, fungal
(b) Encephalitis
Vasculitis
(1) Primary
(a) Primary angiitis of CNS
(2) Secondary
(a) Post-infectious
(i) Varicella
(ii) Other
(b) Infectious
(i) Encephalitis
(ii) Meningitis
(c) Associated with collagen vascular disease or systemic
vasculitides
Table 1: Continued.
Other vasculopathies
(1) Transient/focal cerebral arteriopathy
(2) Down syndrome
(3) Fabry disease
(4) NF1
(5) PHACE syndrome
(6) Sickle Cell Disease
(7) Moya-Moya Disease (primary)
(8) Moya-Moya Syndrome (secondary)
(a) Down syndrome
(b) NF1
(c) SCD
(d) William syndrome
(e) Post-irradiation
(9) Fibromuscular dysplasia
(10) Vasospasm
(a) Migraine
(b) Other
(11) Dissection
Other
(1) Trauma
(a) Dissection
(b) Fat/air embolism
(2) Toxins/Drugs
(a) Cocaine
(b) L-asparaginase
(c) Oral contraceptives
(3) Metabolic
(a) Shock/dehydration
(b) Carbohydrate deﬁcient glycoprotein syndrome
(c) Homocysteinuria
Deep venous thrombosis can be accompanied by haem-
orrhage into the ventricles, as a result of blockage, and
hypertension in the deep venous drainage system [47].
Presumed perinatal ischemic stroke is a subgroup of
perinatal stroke and encompasses imaging-conﬁrmed focal
infarction, which may be venous or arterial, presenting after
the neonatal period [48].
PerinatalVenousInfarction(PVI)isoneoftheseperiven-
tricular infarction syndromes and is an underrecognized
cause of congenital hemiplegia [29, 35].
Risk factors and causes of CSVT are summarized in
Table 2.
2.2. Hemorrhagic Stroke. Most nontraumatic hemorrhagic
strokes are intracerebral hemorrhages, which may also4 Stroke Research and Treatment
Table 2: Risk factors and causes of CSVT.
(1) General
(a) Dehydration
(b) Infection
(c) Fever
(d) Hypoxic-ischemic injury
(e) Post lumbar puncture
(2) Head and neck infections
(a) Otitis media and mastoiditis
(b) Meningitis
(c) Sinusitis
(d) Upper respiratory tract infection
(3) Other head and neck disorders
(a) Head injury
(b) Post intracranial surgery
(c) Hydrocephalus (±ventriculoperitoneal shunt)
(4) Anemia
(a) Iron deﬁciency
(b) Sickle cell disease
(c) Thalassemia
(d) Autoimmune hemolytic anemia
(e) Paroxysmal nocturnal hemoglobinuria
(5) Autoimmune disorders
(a) Behc ¸et disease
(b) Systemic lupus erythematosus
(c) Antiphospholipid antibody syndrome
(d) Inﬂammatory bowel disease (ulcerative colitis, Crohn
disease)
(e) Thyrotoxicosis
(f) Cushing syndrome
(g) Idiopathic thrombocytopenic purpura
(6) Malignancy
(a) Leukemia
(b) Lymphoma
(c) Central nervous system tumors
(7) Cardiac disease
(a) Cyanotic congenital heart disease
(b) Post-operative
(c) Postcatheterization
(8) Renal disease
(a) Nephrotic syndrome
(b) Hemolytic-uremic syndrome
(9) Drugs
(a) L-Asparaginase
(b) Oral contraceptives
(c) Corticosteroids
(d) Epoetin-α
(10) Chromosomal disorders
(a) Down syndrome
(11) Metabolic conditions
(a) Diabetic ketoacidosis
(b) Homocystinuria
Table 3: Risk factors and causes of Hemorrhagic Stroke.
Genetic vasculopathy
(1) Arteriovascular malformation
(2) Intracranial aneurysm
(3) Cavernous angioma
(4) Neurocutaneous disorders
(5) Ehlers-Danlos syndrome
(6) Moya-Moya Syndrome
(7) Fibromuscular dysplasia
(8) Fabry disease
Hematologic disorders
(1) Hemoglobinopathy
(2) Platelet disorders
(3) Coagulopathy
(4) Hypoﬁbrinogenemia
Trauma
Hypertension
(1) Congenital adrenal hyperplasia
(2) Stimulant drug use
(3) Coarctation of aorta
originate in or extend into the intraventricular, subdural, or
subarachnoid space [43, 44].
Risk factors and causes of HS are summarized in Table 3.
Studies about children with HS show that ﬁrst cause is
vascular malformations, which are responsible of 5%–29%
of cerebral hemorrhages, whereas other causes are hemato-
logical disorders, such as thrombocytopenia or hemophilia,
and neoplasms [43, 44].
The most common vascular malformations are arte-
riovenous malformations (AVMs), aneurysms, and cav-
ernous malformations [43, 44]. Aneurysms and hyperten-
sion, although commonly associated with adult HS, are an
infrequent cause in children [45].
Most AVMs are diagnosed in patients between 20 and
40 years, but about 18% to 20% will become symptomatic
during childhood [44, 49]. In a series of 37 children with
AVMs, 70% presented with HS; the annual risk of HS in
children with an AVM is 3.2%, and the risk of recurrent
relapsing is 6%–33% in the ﬁrst year after the initial bleed
[50, 51].
The incidence of intracranial aneurysms in children is
about 1 per million per year, substantially less than the adult
rate [43, 44] .A b o u t1 %t o2 %o fa n e u r y s m sw i l lb e c o m e
symptomatic in childhood, mainly with HS.
3. ClinicalPresentation
The clinical presentation of AIS is extremely various,
depending on age, cause, and involved vascular territory
[9, 23]. Usually, embolic stroke tends to present suddenly,
whereas thrombosis may have a more gradual onset [9, 23].
Focal neurologic deﬁcits (cranial nerve palsies, hemiparesis,
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of AIS in children. Seizures, headache, language and speech
diﬃculties, and altered mental status are also possible [9,
52]. Stroke in the posterior circulation can present as
ataxia, vertigo, and vomiting. In infancy, typical presentation
includes seizure, lethargy, and/or apnea often without focal
neurologic deﬁcits [9]. Pediatric stroke can also impact
behavioural and psychiatric functions.
TheclinicalpresentationofHSdependsonthechild’sage
and the size and location of the hemorrhage. Main signs and
symptoms include headache, vomiting, seizures, impaired
consciousness, and/or focal neurologic deﬁcits [44].
The clinical manifestations of CSVT arenonspeciﬁc, may
be subtle and may overlap with predisposing conditions
such as infection and dehydration. Seizures, altered levels of
consciousness and encephalopathy, focal neurologic deﬁcits
and diﬀuse neurologic symptoms (headache, nausea, and
vomiting) may result; presentation with pseudotumor cere-
bri and isolated headache has also been documented [22].
4.RadiologicalDiagnosis
Key points in the diagnosis of childhood stroke are causal
investigation, laboratory tests, and imaging studies.
Radiological exam is often the ﬁrst step in the evaluation
of an acutely ill child.
The two imaging modalities to be used in emergency are
Computed Tomography (CT) and/or Magnetic Resonance
(MR).
Which is the ﬁrst-choice imaging modality is still object
of debate.
Our experience, derived from acute and followup obser-
vationof41patients,permitstoconsiderMRimaging(MRI)
as ﬁrst-line emergency examination [4].
In fact MRI, especially with the integration of diﬀusion-
weighted (DWI) and perfusion-weighted (PWI) imaging, is
optimal for diagnosing stroke. DWI is the most sensitive
tool in the diagnosis of cytotoxic edema, thus oﬀering the
uniquepossibilityofdiagnosinganacuteischemicstrokealso
in cases with apparently normal CT and MRI conventional
sequences [4]( Figure 1). Moreover, perfusion imaging can
oﬀer a prognostic value: in acute stroke, in fact, it allows
to determinate the volume of tissue at risk and the vascular
distribution of the ischemia; the level of perfusion to the
ischemic tissues may also help to determine the relative
beneﬁts and risks of a given therapy [53]. It is well known,
in fact, that the perfusion/diﬀusion “mismatch” reﬂects
the diﬀerence between the ischemic core and surrounding
penumbra: the areas of DWI abnormalities with decreased
ADC values are assumed to have suﬀered irreversible injury,
by the time of patient examination; hence, an area of lowered
PWI and normal DWI is an index of the penumbra, or tissue
that has potentially reversible ischemia. These values had
been recently considered as useful screening for systemic or
intra-arterial thrombolysis approach in adulthood.
The role and the indications of intra-arterial thrombol-
ysis in pediatric stroke has not been deﬁnitively assessed yet
becauseaveryfewcaseshavebeenreportedandclinicaltrials
are in course. Anyway, as reported in literature, outcomes of
children with stroke who underwent thrombolysis, suggest
that this treatment may also be beneﬁcial in pediatric
population. Controlled randomized trials are needed in
order to determine the appropriate dosage, safety, and eﬃ-
cacy of intra-arterial thrombolysis; feasibility of mechanical
thrombolysis should be evaluated as well [54–57].
On the other hand, the use of MR angiography (MRA)
allows the detection and location of intracerebral arterial
lesionsinanoninvasiveway,althoughthecharacterizationof
the type of lesion is the main limit of MRA (circumferential
clefts, intimal ﬂaps, intraluminal thrombi, or tapering of
middle cerebral artery branches) [58].
MR spectroscopy (MRS) and DWI with MRA could
also, in selected cases, increase the sensitivity of MRI in
the detection of ischemia and infarction [59]. According to
English guidelines, cross-sectional brain imaging is manda-
tory in children presenting with clinical stroke, and brain
MRI is recommended for investigation in these patients [25].
Brain MRI should be undertaken as soon as possible after
presentation. If brain MRI will not be available within 48
hours, CT is an acceptable initial alternative [25]. Brain
imaging should be undertaken urgently in children with
clinical stroke who have a depressed level of consciousness
at presentation or whose clinical status is deteriorating, in
which case CT scanning should be used.
If the identiﬁed infarct has unusual features, more spe-
ciﬁc venous imaging investigations may then be applied by
the radiologist as necessary. In the ﬁrst instance, noninvasive
o p t i o n ss u c ha sM Rv e n o g r a p h y( M R V )o rC Tv e n o g r a p h y
(CTV) are preferred over intra-arterial digital subtraction
angiography (IADSA) [25].
MRI and MRV are actually the preferred methods
for investigation of CSVT because of their sensitivity and
speciﬁcity and for the excellent anatomical correlation
between venous drainage system and location of parenchy-
mal infarcts. DWI and PWI may play a role in detecting
venous congestion in cerebral venous thrombosis and in the
diﬀerentiation of cytotoxic and vasogenic edema, but do not
diﬀerentiate venous from arterial infarction.
The diagnosis is established by demonstrating a lack of
ﬂow in the cerebral veins with or without typical images of
brain infarction [22].
MRI and MRV allow to demonstrate both the infarct
and the clot within the vessels. On MRI, the thrombus is
easily recognizable in the subacute phase, when it appears
hyperintense on T1-weighted images. In the acute phase, the
thrombus is isointense with brain on T1-weighted images
and hypointense on T2-weighted images. This appearance
can be mistaken for ﬂowing blood (Figure 2), but MRV
will demonstrate an absence of ﬂow in the thrombosed
sinus. T2∗-weighted images seems to be more sensitive than
T1- or T2-weighted or Fluid Attenuated Inversion Recovery
(FLAIR) images in demonstrating venous thrombosis and
associated hemorrhage [60].
When MRI exam cannot be performed, unenhanced CT
may detect deep venous thrombosis as linear densities in
the expected locations of the deep and cortical veins. As the
thrombus becomes less dense, contrast may demonstrate the
“empty delta” sign, a ﬁlling defect, in the posterior part of6 Stroke Research and Treatment
(a) (b)
(c) (d)
Figure 1: A 14-year-old male with right-sided hemiparesis started 3 hours before MRI. (a) Plain CT scan does not show signiﬁcant density
abnormality. (b) MRI T2-weighted Fluid Attenuated Inversion Recovery image does not show signiﬁcant signal intensity abnormality of
cerebral parenchyma even if hyperintensities of distal branches of middle cerebral artery are visible and suggest vessel occlusion (arrow). (c)
MRI Diﬀusion-weighted image shows bright signal of left insular and temporal cortex indicating cytotoxic edema (arrows). (d) 3D-Time of
Flight MR-angiogram shows poor representation of distal branches of left middle cerebral artery (arrows).
the sagittal sinus (Figure 2). However, CT scan with contrast
misses the diagnosis of CSVT in up to 40% of patients [22]
so CTV can be a reasonable in-depth examination.
In every case, imaging of the cervical and proximal
intracranial arterial vasculature should be performed in all
children with AIS and imaging of the cervical vasculature to
exclude arterial dissection should be undertaken within 48
hours of presentation with AIS [25]. Transthoracic cardiac
echocardiography should be undertaken within 48 hours
after presentation in all children with AIS [25].
The limit usually attributed to MRI, related to the length
of the examination, can be easily overcome by the use of
dedicated “fast protocols”.
Another limit classically attributed to MRI, is its pre-
sumed reduced sensitivity to acute bleeding, but diﬀerent
studies [4, 61] report that MR is always able to identify
the acute bleeding and to distinguish spontaneous intracra-
nial hematoma from the hemorrhagic transformation of
ischemic stroke. Moreover, even when intracranial bleed-
ing is diagnosed with CT, identiﬁcation of the cause ofStroke Research and Treatment 7
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Figure 2: A 16-year-old female with progressively worsening headache, generalized seizures on the 4th day and coma on the 5th day. MRI
exam was performed on the 5th day. MRI T2-weighted Turbo Spin Echo (a) and T2-weighted Fluid Attenuated Inversion Recovery images
(b) show altered signal intensity involving bilaterally medial thalamus, lentiform nucleus, and caudate nucleus. Intraventricular bleeding is
present and hemorrhagic infarct involving right frontoparietal junction (not shown) was also detected. Superior sagittal sinus and internal
cerebralveinsseemtohaveregular“ﬂowvoid”signal(arrows),duetothedarksignalofsubacutethrombus.MRIT1-weightedimagesbefore
(c) and after (d) administration of contrast agent better show occlusion of superior sagittal sinus, vein of Galen and internal cerebral veins
(arrows). Visible advanced signs of venous stasis and the so-called “delta sign” (arrow) (d).
hemorrhage is often diﬃcult without MR. In fact, MR is
rapidly able to recognize the cause of the hemorrhage, and
identify the presence of vascular malformations eligible to
surgical or interventional treatment (Figures 3 and 4)[ 4].
The “real” limitation of MRI is probably the need
for cooperative patients or for sedation. In most cases,
anaesthesiological support, for both sedation and clinical
monitoring, is required; CT, otherwise, is much faster and
can be more easily performed even on unstable patients.
Considering that many pediatric patients are comatose
or already under general sedation before being transferred
to diagnostic imaging, MRI can be proposed as the ﬁrst-
choice examination even in the acute phase of a stroke
[4]. Moreover, in selected cases where diﬀerential diagnosis
includes nonischemic pathology, use of paramagnetic con-
t r a s ta g e n tc a nb eu s e ds a f e l y .C Ts h o u l db ep e r f o r m e do n l y
on uncooperative/unstable patients and when MRI is not
available; after overcoming of the critical phase it is anyway
recommended that MRI is performed in the immediate
followup [4].
Moreover, even if CT is very sensitive and speciﬁc in
the detection of hemorrhagic lesions, in the acute phase
of cerebral infarction, parenchymal abnormalities may be
subtle on CT, and early/small lesion(s) in the posterior fossa
can be missed [9].
CT angiography (CTA) is a noninvasive method for
evaluation of intra, and extracranial circulation. CTA per-
formed in early stages of cerebral ischemia may provide
crucial information regarding cerebral circulation [62].
Disadvantages of CTA include radiation exposure, use of
intravenouscontrast,andthediﬃcultyintimingthecontrast
bolus in small children [9].
As mentioned before also MRI and MRA supply pre-
cise information regarding intra, and extracranial vascular
lesions, especially in craniocervical arterial dissections. The
presence on intramural hematoma can be assessed with
cross-sectional T1-, T2-, and PD-weighted images while a
global visualization of vessel structure can be obtained with
MRA. Time-of-ﬂight (TOF) MRA can demonstrate a T1
hyperintense intramural clot, whereas phase-contrast (PC)
MRA and contrast-enhanced (CE) MRA demonstrate only
the vessel lumen [63–65]. Diagnosis of cervical artery dissec-
tion with cross-sectional images depends on the characteris-
ticsoftheintramuralhematoma,surroundingstructuresand
MR sequences. An optimal exam should include T1- and T2-
weighted with and without fat suppression and PD-weighted
sequences. Subacute hematoma appears on fat suppressed
T1-weighted images as a crescent-shaped hyperintense area
around an eccentric ﬂow void corresponding to the vessel
lumen. Acute dissection can be missed on fat suppressed
T1-weighted images because isointense hematoma may be
obscured when surrounded by isointense tissues [64, 65].
The gold standard for the deﬁnitive assessment of
cerebral vasculature is IADSA which should be considered
in children when pathology of small distal artery is suspected
and with an unexplained infarct or hemorrhage not eluci-
dated by MRI or MRA evaluation [66].
IADSA is used to diagnose MMD, showing bilateral
stenosis of the internal carotid artery and the development
of a collateral network (rete mirabile) with the appearance
of the typical pattern known as “puﬀ of smoke” (Figure 5),
or in suspected dissection [9, 36]. MRI and MRA, and in
some cases IADSA, should be repeated in cases of identiﬁed
arteriopathies 3 to 6 months after the initial investigation,
and again at 6 to 12 months in most patients, and at the
appearance of any new clinical manifestations to evaluate for
additional subclinical infarcts and progression or regression
of previously identiﬁed vasculopathy [9, 67].8 Stroke Research and Treatment
(a) (b)
(c) (d)
Figure 3: A 5-year-old male with sudden onset of visual defect followed by generalized seizures without previous hepileptic history. (a)
Plain CT scan showing grossly calciﬁed extracerebral occipital mass with loss of brain tissue. (b) MRI T1-weighted image shows typical
“salt and pepper” mixed signal in the mass. (c) MRI T2-weighted Turbo Spin Echo image shows the same mass with features indicating
hemosiderine rim and diﬀerent stages of blood clot. (d) MRI T2∗-weighted Fast Field Echo image conﬁrms susceptibility sensitive signal
consistent with blood degradation products and diﬀerent stages of bleeding. All MRI features suggested the diagnosis of giant, mostly
extracerebral cavernoma, surgically conﬁrmed.
5. Conclusions
Pediatric stroke is a dramatic disease that requires urgent
multidisciplinary competence and approach.In both cases of
ischemic and hemorrhagic origin, the radiological approach
to be obtained in emergency leads to the ﬁrst screening and
the ﬁrst therapeutic possibility. Our and others experience
suggest that in cooperating children as well as in comatose
one or in patients already under general anesthesia, MRI
should be considered as the ﬁrst diagnostic step, oﬀering a
complete diagnostic set of information. In cases in which
MRI is not available or in noncooperative children, it is
recommended to perform a CT scan as ﬁrst diagnostic step,
followed as soon as possible by an MRI study.Stroke Research and Treatment 9
(a) (b) (c)
Figure 4: A 17-year-old male with headache, neck stiﬀness, and right hemiparesis. (a) Plain CT scan shows left frontal intraparenchymal
hemorrhage (arrow). (b) MRI T2-weighted Turbo Spin Echo performed 4 days after surgical evacuation of hemorrhagic lesion shows the
cause of bleeding: an arteriovenous malformation (arrow). (c) Intra-arterial digital subtraction angiography conﬁrms and better evaluates
the arteriovenous malformation (arrow).
(a) (b) (c)
Figure 5: A 15-year-old male presenting with transient right hemiparesis. (a) MRI T2-weighted Turbo Spin Echo image shows vascular
abnormality in left portion of the circle of Willis (arrow). (b) MR-angiogram shows a progressive reduction of diameter of the supraclinoid
internal carotid artery associated with occlusion of the origin of left middle cerebral artery (curved white arrow) and presence of tiny newly
formed compensatory network (white arrows). (c) Intra-arterial digital subtraction angiography better shows the occlusion of left middle
cerebral artery and the typical presence of tortuous tiny vessels appearing as the so-called “puﬀ of smoke” (“moya-moya”) (arrow), formed
to compensate for the supply blockage.
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